Panacea Biotec Limited v. Sanofi Healthcare India Private Limited
Case brief
What is this about?
This order disposes of the commercial suit CS (Comm) 224/2021 and pending applications based on an agreed settlement. The defendant withdraws patent oppositions, agrees not to launch the product Shan6 in India for the present, and provides a 30-day notice if it resumes commercial activities.
What did the court decide?
The suit and pending applications are disposed of in terms of the settlement agreement where the defendant withdraws oppositions and agrees not to commercially launch Shan6 in India.